Preclinical Efficacy of the Combination of Met and Src Family Kinase Inhibitors in Triple-Negative Breast Cancer.

被引：0
|
作者：
Gartner, E. M. [1 ]
Kim, E. M. H. [1 ]
Choi, L. [1 ]
Boerner, J. [1 ]
机构：
[1] Wayne State Univ, Karmanos Canc Ctr, Detroit, MI USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P008-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD08-08
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Chemotherapy-related outcomes in triple-negative breast cancer.
    Wellmann, Rebecca M.
    Ghafouri, Sanaz N.
    McAndrew, Nicholas Patrick
    Hurvitz, Sara A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Lymphatic and vascular invasion patterns in triple-negative breast cancer.
    Yaman, S.
    Gumuskaya, B.
    Ozkan, C.
    Aksoy, S.
    Guler, G.
    Altundag, M. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Survival outcomes across ethnicities in triple-negative breast cancer.
    Rushton, Moira Katherine
    Zhang, Tinghua
    Song, Xinni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.
    O'Shaughnessy, Joyce
    Osborne, Cynthia
    Pippen, John E.
    Yoffe, Mark
    Patt, Debra
    Rocha, Christine
    Koo, Ingrid Chou
    Sherman, Barry M.
    Bradley, Charles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (03): : 205 - 214
  • [35] Distinct immune microenvironments stratify triple-negative breast cancer.
    Gruosso, Tina
    Kumar, Venkata Satya
    Gigoux, Mathieu
    Saleh, Sadiq
    Bertos, Nicholas
    Omeroglu, Atilla
    Zuo, Dongmei
    Meterissian, Sarkis
    Haibe-Kains, Benjamin
    Park, Morag
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 17 - 17
  • [36] MYC as a therapeutic target for the treatment of triple-negative breast cancer.
    Foley, Sarah A.
    Casten, Alina
    Kavanagh, Emma
    Synnott, Naoise C.
    Crown, John
    Larsson, Lars-Gunnar
    Duffy, Michael J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Patterns of mutation enrichment in metastatic triple-negative breast cancer.
    Saravia, Cesar H.
    Flores, Claudio J.
    Schwarz, Luis Jesus
    Bravo, Leny
    Zavaleta, Jenny
    Araujo, Jhajaira M.
    Neciosup, Silvia P.
    Pinto, Joseph A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Targeting the RXR pathway for the prevention of triple-negative breast cancer.
    Moyer, Cassandra
    Hill, Jamal
    Coleman, Darian
    Sei, Shizuko
    Mohammed, Altaf
    Sanders, Martin
    Brown, Powel
    Mazumdar, Abhijit
    [J]. CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [39] Characterizing the gut microbiome of patients with triple-negative breast cancer.
    Swoboda, April T.
    Sharma, Anukriti
    Olopade, Olufunmilayo I.
    Nanda, Rita
    Gilbert, Jack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] The prognostic impact of age in patients with triple-negative breast cancer.
    Liedtke, C.
    Gluz, D.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345